Horizon Space Acquisition Ii CORP Form 4 insider transactions

CEO Mingyu Li files an exit Form 4 following the consummation of Horizon Space Acquisition II Corp.'s initial business combination.

Cai Tianchen voluntarily files Form 4 to report no longer serving as director or holding shares of Horizon Space Acquisition II Corp. after its business combination on June 12, 2026.

Chief Financial Officer Zhai Min has ceased serving as an officer of Horizon Space Acquisition II Corp. following the company's business combination.

Director Qian Xu has ceased serving on the board of Horizon Space Acquisition II Corp. following the company's business combination.

Horizon Space Acquisition II Corp. announced a $7.8 million PIPE financing to support its business combination with SL BIO Ltd., forming SL Science Holding Limited.

Horizon Space Acquisition II Corp. announced a $7.8 million private investment in public equity (PIPE) financing to support its business combination with SL BIO Ltd., forming SL Science Holding Limited.

Horizon Space Acquisition II Corp. announced a $7.8 million private investment in public equity (PIPE) financing to support its business combination with SL BIO Ltd.

Horizon Space Acquisition II Corp. and SL BIO Ltd. announced the addition of two independent director nominees and updated beneficial ownership ahead of their business combination meeting.

Horizon Space Acquisition II Corp. (HSPT) announced two new independent director nominees for SL Science Holding Limited (PubCo) ahead of its business combination with SL BIO Ltd., updating beneficial ownership details.

Horizon Space Acquisition II Corp. supplements its proxy statement by adding two independent director nominees for the combined entity with SL BIO Ltd.

Horizon Space Acquisition II Corp. clarifies the redemption process for its upcoming shareholder meetings regarding the proposed business combination with SL BIO Ltd. and extension proposals.

Horizon Space Acquisition II Corp. (HSPT) issued a press release clarifying the redemption process for its upcoming Business Combination Meeting with SL BIO Ltd. and an Extension Meeting.

Horizon Space Acquisition II Corp. issued a press release clarifying the redemption process for its upcoming Business Combination and Extension shareholder meetings.

Horizon Space Acquisition II Corp. has postponed its extraordinary general meeting for the proposed business combination with SL BIO Ltd. to February 12, 2026, to allow for further shareholder engagement.

Horizon Space Acquisition II Corp. has postponed its extraordinary general meeting for the proposed business combination with SL Bio Ltd. to February 12, 2026, extending the redemption deadline to allow more shareholder engagement.

Horizon Space Acquisition II Corp. has postponed its extraordinary general meeting to vote on the business combination with SL BIO Ltd. to February 12, 2026, extending the redemption deadline.

Horizon Space Acquisition II Corp. filed an 8-K to correct contact information for its trust and transfer agents in the definitive proxy statement for its proposed business combination with SL BIO Ltd.

Horizon Space Acquisition II Corp. filed an 8-K to correct trust and transfer agent contact information and redemption details in its definitive proxy statement for the upcoming SL Bio business combination vote.

Horizon Space Acquisition II Corp. (HSPT) filed an 8-K to correct trust and transfer agent details in its definitive proxy statement for the upcoming business combination vote with SL BIO Ltd.